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27.1 INTRODUCTION
In the setting of a sick building, sometimes sporadically, there are some occupants who
report extreme sensitivity to a host of exposures, ranging from new carpet and paint odors
to cleaning agents and offgassing from office equipment. Because these persons are in the
minority, their complaints tend to be ignored. They suffer from an enigmatic condition
known as multiple chemical sensitivity, or multiple chemical intolerance.
These individuals report multiple symptoms, including severe headaches, fatigue, mus-
cle pain, memory and concentration difficulties, various skin conditions, shortness of
breath, and a variety of gastrointestinal problems, which they report being triggered by
common, low-level chemical exposures and various foods and drugs. Some have been
diagnosed with chronic fatigue syndrome or fibromyalgia. There is growing concern
among scientists that indoor air contaminants may not only trigger their symptoms, but may
cause the illness itself. These individuals are not to be ignored. They are often the key to
understanding indoor air problems in a building.
Susceptibility to indoor air contaminants varies greatly from person to person, perhaps
by several orders of magnitude. Building managers and indoor air quality (IAQ) specialists
need to be on the lookout for these "canaries," individuals who may be more susceptible to
low-level air pollutants, for a variety of reasons'. First, their health concerns tend to drive
the building investigation process. Until they feel better or until the building is ruled out as
a cause for their symptoms, air quality concerns will fester, as other occupants tend to
regard these individuals as barometers for the building's health. Second, these individuals
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can often help locate problem sources that re tt identifiable by air sampling or other test-
ing methods. Third, addressing sensitive individuals' concerns openly and honestly makes
good risk management sense and will help prevent compensation claims, disability dis-
putes, and litigation.
These chemically intolerant individuals report disabling symptoms when exposed to
myriad substances, e.g., fragrances, tobacco smoke, diesel exhaust, as well as particular
foods, medications, alcoholic beverages, and caffeine-intolerances that sometimes, but
not always, predate their difficulties in the building by years, even decades. The chemically
intolerant are showing up in increasing numbers in the waiting rooms of occupational/
environmental medicine doctors and allergists, yet little is currently known about the
underlying disease that afflicts them.
One thing we do know is that chemically intolerant people appear in a variety of set-
tings, ranging from manufacturing plants, offices, schools, and farms, to hospitals, court-
houses, and casinos. Those affected report multisystem symptoms and new-onset
chemical, food, and drug intolerances that never bothered them before their "initiating"
exposure event. Scientists have described this breakdown in tolerance, referred to by some
as toxicant-induced loss of tolerance (TILT), among different demographic groups in
more than a dozen countries. Research in this area is in its infancy. Nevertheless, there
remains the potential for liability if, in the future, indoor air exposures are shown to initi-
ate TILT, resulting in long-term disability.
Investigators responding to IAQ complaints must consider all possible etiologies,
weighing the relative contributions of contaminant sources, HVAC system deficiencies,
occupant load, and physical factors (temperature, humidity, etc.), and, no less importantly,
the susceptibility of the occupants themselves. Chemically intolerant individuals represent
an estimated 2 to 6 percent of the population. They spend time in office buildings, schools,
homes, and public buildings. To a great extent, their needs will dictate the design, con-
struction, and operation of twenty-first century indoor environments. This has already
begun. The Canada Mortgage and Housing Corporation (CMHC) has sponsored several
prototype residential housing units for the chemically intolerant, educating and encourag-
ing Canadian builders to adopt practical approaches to protect this subset of the population.
27.2 HISTORICAL BACKGROUND
In the 1950s, an allergist named Theron Randolph described a phenomenon he called chem-
ical susceptibility in a cosmetic saleswoman suffering from asthma, fatigue, irritability,
depression, and intermittent loss of consciousness. Her symptoms seemed to flare when-
ever she was exposed to "man-made combustion products and derivatives of gas, oil, and
coal" (Randolph 1962, Randolph and Moss 1980). Other physicians, noting similar prob-
lems in their patients and even themselves, allied with Randolph. In 1965, Randolph and
his adherents broke away from the allergists' organizations and founded the Society for
Clinical Ecology (renamed the American Academy of Environmental Medicine in 1984).
Many clinical ecologists adopted various unorthodox diagnostic and treatment approaches,
going well beyond Randolph's original teachings. Most, however, continued to employ his
central diagnostic/therapeutic approach, i.e., trial avoidance of potential chemical and food
incitants followed by judicious reexposure to determine which ones trigger symptoms.
Position papers by several influential medical societies (American Academy of Allergy and
Immunology 1981, 1986; American College of Physicians 1989; American Medical
Association 1992) challenged the ecologists' claims. Over the past decade, there has been
an outpouring of technical reports, concept papers, and hypotheses about this illness.
People on all sides of the issue seem to think its prevalence is on the rise. Some physicians
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and researchers attribute this surge of patients and interest to (1) increased synthetic organic
chemical production and use since World War II (including pesticides), coupled with (2)
decreased fresh air exchange indoors due to energy conservation efforts following the oil
embargo of the mid-1970s. Others attribute it to increased media attention and public
awareness of environmental exposures.
Recently, there has been a softening of positions taken against the illness (Ashford and
Miller 1998, ACOEM 1999). Although concerns about unproved diagnostic and treatment
practices continue, affected individuals are turning to board-certified occupational and
environmental medicine physicians and toxicologists in universities. In 1987, Mark Cullen
of Yale edited a collection of papers entitled Workers With Multiple Chemical Sensitivities:
An Overview, offering a spectrum of authors' opinions on the illness (Cullen 1987). He rec-
ommended the name multiple chemical sensitivity (MCS), and offered the first of several
proposed case definitions for it: "Multiple chemical sensitivity (MCS) is an acquired dis-
order characterized by recurrent symptoms, referable to multiple organ systems, occurring
in response to demonstrable exposure to many chemically unrelated compounds at doses
far below those established in the general population to cause harmful effects. No single
widely accepted test of physiologic function can be shown to correlate with symptoms."
The terms multiple chemical sensitivity and environmental illness now appear on the
National Library of Medicine's bibliographical database, MEDLINE. While there is gen-
eral agreement that an illness exists, and that these patients suffer, medical opinion con-
cerning the nature and origin of the phenomenon remains polarized. At the debate's core is
the question, "Is MCS the result of chemical exposures, psychological factors or some mix
of these?" The mix might also vary from person to person. If chemical exposures can cause
MCS, the repercussions for environmental policy, product liability, compensation, and
medical treatment, will be monumental.
Canada was the first nation to examine this problem through its 1985 Thomson Report
(Thomson 1985) and subsequent sponsorship of clinical studies. In the United States, the
issue has been examined by several states (New Jersey, Maryland, and California)
(Ashford and Miller 1989, Bascom 1989, Kreutzer et al. 1999), federal environmental
agencies (ATSDR 1994, Fiedler and Kipen 1997a), the National Academy of Sciences
(NRC 1992), and various professional organizations (AOEC 1992, ACS 1999). Proposed
research strategies have evolved from these meetings (summarized in Ashford and Miller
1998), but few comprehensive or illuminating studies have been funded. Amid the confu-
sion of opinion swirling around the problem, affected individuals and those who wish to
help them are in need of safe, rational, interim approaches that might help alleviate the
condition. Of equal importance, there is a need for practical strategies (e.g., integrated pest
management, reducing VOC levels in new construction) to prevent the illness from devel-
oping in other people.
27.3 DEFINING SENSITIVITY AND INTOLERANCE
The different meanings ascribed to the term sensitivity may have added to the confusion
surrounding this illness. "Sensitivity" is used in three relatively distinct ways (Ashford et
al. 1995):
1. The heightened responses of certain individuals to known toxicants or allergens, e.g., the
responses of susceptible persons to toxic substances like mercury and carbon monoxide,
or allergic reactions to antigens like housedust mites and animal dander.
2. The responses of certain individuals to identifiable exposures that at this time cannot be
explained by generally accepted disease mechanisms. This category includes:
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a. Sick building syndrome (SBS) involving individuals who respond to one or several
air contaminants that may or may not be identifiable. The fact that affected individ-
uals' symptoms resolve when they leave the building provides evidence for SBS.
b. Sensitivity, such as that induced by toluene di-isocyanate (TDI), that starts out as
specific hypersensitivity to a single substance (or one chemical class), but evolves
into nonspecific hyperresponsiveness (described further in category 3 below).
3. The heightened, extraordinary, or unusual responses of certain individuals to struc-
turally diverse chemicals at exposure levels orders of magnitude below those producing
symptoms in most people (cf. Cullen 1987).
Patients with MCS appear to exhibit this third type of sensitivity. Synonyms and related
terms include environmental illness (ED), chemical intolerance, ecological illness, idiopathic
environmental intolerance (IEI), universal allergy, and toxicant-induced loss of tolerance
(TILT). Proposed underlying mechanisms range from entirely psychogenic to entirely toxi-
genic, and everything in between (Ashford and Miller 1998, ACS 1999, NRC 1992, AOEC
1992, ATSDR 1994). Odor conditioning is one example of a possible dual toxigenic-psy-
chogenic mechanism (Doty et al. 1988). A bright line should be drawn between this third
type of sensitivity and antibody-mediated sensitivities, or allergies. Allergists prefer the term
chemical intolerance over chemical sensitivity in order to distinguish this condition from
true allergies. We also prefer the term chemical intolerance because it describes these indi-
viduals' responses without presuming any specific mechanism, allowing time for the science
to unfold. Sensitivity, on the other hand, implies an underlying sensitization process, when,
in fact, the loss of tolerance these individuals describe may result from something entirely
different, e.g., cell membrane disruption or gene activation. For the remainder of this chap-
ter, we will therefore use the term chemical intolerance or multiple chemical intolerance in
preference to chemical sensitivity or multiple chemical sensitivity. Tolerance is defined as
the ability to withstand an insult. Affected individuals appear to lose their prior natural or
innate tolerance for a wide spectrum of substances.
Researchers have observed multiple chemical intolerances occurring in a minority of
sick building occupants (type 2a), with some people developing profound illness marked
by multisystem symptoms and multiple intolerances. Many of these people ultimately
adopt constricted lifestyles that transform their careers, families, social life, ability to
travel, and recreational pursuits. Even their selection of home furnishings and clothing is
dictated by their striving to avoid problem exposures.
27.4 PHENOMENOLOGY
Chemically intolerant individuals often say their illness began following specific exposure
events, referred to as initiating events, e.g., a chemical spill, repeated exposure to solvents,
Case Study 1. Multiple Chemical Intolerance Following Pesticide Use
A "mystery illness" involving some 250 people broke out at a major casino resort hotel following
repeated application of propoxur, a carbamate insecticide, used for cockroach control. Affected
individuals reported dizziness, weakness, nausea, sore throat, fainting, sweating, headaches, rac-
ing heartbeat, shaking and trembling, lip and facial tingling, and red, splotchy rashes. While most
recovered, 19 people experienced persistent symptoms. When these individuals were seen in an
occupational medicine clinic 9 to 15 months after the initial episode, 12 of the 19 (63 percent)
reported intolerances to perfume, gasoline, newsprint, cleaning materials, pesticides, and various
other solvents that had not bothered them before the casino exposure (Cone and Sult 1992).
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a pesticide application, indoor air contaminants associated with new construction, combus-
tion products, etc. (Miller 1994) (see Case Studies 1 to 3). A subset of those exposed in these
situations appear to evolve to a chronic condition that can persist many years, even decades,
beyond the initial exposure. At first, individuals describe "flu-like" symptoms that will not
go away, or feeling as though they are in a "perpetual fog." Next to develop are multisystem
symptoms that seem to wax and wane unpredictably and a dawning awareness of a few new
intolerances or adverse reactions, e.g., to alcohol or medications. Over time, these intoler-
ances spread to a wide variety of everyday exposures -chemicals, foods, drugs, caffeine,
alcoholic beverages, and skin contactants. The intolerances may appear within weeks of an
acute, high-level exposure, or, in the case of lower-level, chronic exposures as in a sick
office building, develop insidiously over months or years. Food intolerances may not be
recognized as such initially; instead, every sort of digestive difficulty, feeling ill after meals,
or extreme irritability if a meal is missed or delayed may be noted. Symptoms may occur fol-
lowing inhalation, ingestion, mucosal contact, or injection (e.g., drugs). Different exposures
(Table 27. 1) -fragrances, chemicals outgassing from new furnishings or carpeting, traffic
exhaust, cleaning agents, etc.-may trigger different constellations of symptoms in differ-
ent individuals. Even the same individual may experience different symptom patterns with
different exposures. There is consistency, however: A particular exposure, e.g., diesel
exhaust or a certain fragrance, in a particular person, reportedly elicits a characteristic con-
stellation of symptoms-a signature response for that person having that exposure.
Responses may occur at below-olfactory-threshold concentrations. Symptoms develop sec-
onds to hours following a triggering exposure, and may persist minutes to days. Responses
. ~ ~ ~ - --
Case Study 2. Multiple Chemical Intolerance at the Environmental Protection Agency's
Headquarters
EPA's Washington, D.C., headquarters building became a "sick building" during an extensive ren-
ovation, which included painting, moving walls, and the installation of 27,000 square yards of new
carpeting. Even before the renovation, some occupants had reported symptoms suggestive of a
potential indoor air quality problem in the building.
The EPA Waterside Mall headquarters building was originally a housing complex, consisting
of two residential towers with a mall between. Residential space was converted to office space for
the agency's use. During the remodeling, more than 100 individuals, including agency scientists,
reported symptoms. Most who were affected improved when corrective measures were taken.
Some office areas were found to have as little as 0.2 air changes per hour. About 2 dozen employ-
ees experienced persistent symptoms, long after the building had outgassed, including malaise,
"spacey" feelings, difficulty thinking, respiratory problems, nausea, headaches, and dizziness.
Symptoms were triggered by various common foods and chemicals, including perfumes, auto
exhaust, and tobacco smoke (Welch and Sokas 1992, Ashford and Miller 1998, EPA 1989, Hirzy
and Morison 1989). Even 10 years later, some of these individuals continue to experience disabling
symptoms triggered by common exposures.
Case Study 3. Multiple Chemical Intolerance in a Manufacturing Facility
Some 50 to 75 aerospace manufacturing workers became acutely ill when a new composite plastic
material was introduced into their workplace. Symptoms included headaches, fatigue, dizziness,
nausea, breathing difficulties, and cognitive disturbances. Industrial hygienists identified phenol,
formaldehyde, and methyl ethyl ketone as principal components, although airborne concentrations
were within established safety limits. Thirty-seven workers filed compensation claims. A panel of
medical specialists found no medical diagnosis or immunological abnormalities that could explain
most workers' symptoms. More than a dozen of the claimants reported persistent, disabling symp-
toms triggered by common environmental exposures (Simon et al. 1990).
- -----
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are diverse and highly individual, ranging in intensity from mild (nasal congestion, nausea,
or slight headache) to severe (mental confusion, depression or seizures) (Table 27.2).
Hyperresponsiveness to physical stimuli, including light, noise and touch, is commonly
reported (Miller and Prihoda 1999a, 1999b). People with no sense of smell (anosmic) still
may report chemical intolerances.
The chemically intolerant appear to constitute a distinct subset of the population. The fact
that normal people do not experience these same symptoms, even when exposed to much
higher concentrations of the same chemicals, has led some doctors to conclude the problem
must be psychogenic. These intolerances to structurally unrelated substances violate funda-
mental tenets of toxicology and allergy, and the symptoms can be almost anything. The con-
dition simply cannot be explained by existing disease paradigms. What is compelling about
the condition is the fact that researchers have described identical patterns of multisystem
symptoms and new-onset intolerances developing in demographically diverse groups in
more than a dozen countries following well-documented chemical exposures. This, more
than anything else, has fueled scientists' search for a new disease paradigm that would
explain these observations. Recently proposed animal models for the condition (Sorg 1999,
Overstreet et al. 1996, Rogers et al. 1999) may offer a new window into the underlying
mechanism. Building managers and IAQ professionals need to bear in mind that medicine
may be in the early observational stages of uncovering a new disease process.
People with multiple chemical intolerances report that avoiding triggering exposures pro-
vides some relief (Lax 1995). Comprehensive avoidance is challenging, as well as socially
isolating; low VOC exposure levels (parts per billion or trillion) are near-ubiquitous.
Symptom-exposure relationships may be difficult to discern for several reasons (Ashford and
Miller 1998): habituation with chronic exposures, e.g., VOCs in a sick office building,
and apposition, i.e., overlapping symptoms resulting from common exposures (chemicals,
foods, drugs), both can hide or "mask" the effects of particular exposures. Many individuals
quit their jobs in order to minimize exposures to fragrances, carbonless copy paper, cleaning
agents, etc., while others switch employers, occupations, and residences, searching for a
safer environment.
TABLE 27.1 Triggering Exposures
Reported by at least 80 percent of 112 people who devel-
oped multiple chemical intolerance following an exposure
to pesticides (n = 37) or indoor air contaminants (n = 75)
New carpeting Enclosed mall
New automobile interior Oil-based paint
Poorly ventilated meeting rooms Particle board
Perfume Gas engine exhaust
Detergent aisle in grocery Hotel rooms
Newspaper/printed materials Phenolic disinfectants
Fresh asphalt/tar Dry-cleaned clothes
Diesel exhaust Insecticides
Felt-tip markers Gasoline
Nail polish/remover Potpourri
Restroom deodorizers New tires
Fabric stores Cigar smoke
Heavy traffic Cigarette smoke
New plastic shower curtain Incense
Hairspray Insect repellent
Source: Miller andMitzel (1995.
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TABLE 27.2 Symptoms Commonly Reported by Chemically Intolerant Individuals
Major categories were derived via factor analysis of symptoms reported by 112 self-identified chem-
ically intolerant people who reported becoming illfollowing exposure to indoor air contaminants
(n = 75) or cholinesterase-inhibiting pesticides (n = 37).
Neuromuscular
Loss of consciousness
Stumbling/dragging foot
Seizures
Print moving/vibrating on page
Feeling off balance
Tingling in fingers/toes
Double vision
Muscle jerking
Fainting
Numbness in fingers/toes
Clumsiness
Problems focusing eyes
Cold or blue nails/fingers
Uncontrollable sleepiness
Head-related
Head fullness/pressure
Tender face/sinuses
Sinus infections
Tightness in face/scalp
Brain feels swollen
Ringing in ears
Headache
Feeling groggy
Musculoskeletal
Joint pain
Muscle aches
Weak legs
Weak arms
General stiffness
Cramps in toes/legs
Painful trigger points
Gastrointestinal
Abdominal gas
Foul gas
Problems digesting food
Abdominal swelling/
bloating
Foul burping
Diarrhea
Abdominal pain/cramping
Constipation
Cardiac
Heart pounding
Rapid heart rate
Irregular heart rate
Chest discomfort
Affective
Feeling tense/nervous
Uncontrollable crying
Feeling irritable/edgy
Depressed feelings
Thoughts of suicide
Nerves feel like vibrating
Sudden rage
Loss of motivation
Trembling hands
Insomnia
Airway
Cough
Bronchitis
Asthma or wheezing
Postnasal drainage
Excessive mucus production
Shortness of breath
Eye burning/irritation
Susceptible to infections
Dry eyes
Enlarged/tender lymph
nodes
Hoarseness
Cognitive
Memory difficulties
Problems with spelling
Slowed responses
Problems with arithmetic
Problems with handwriting
Difficult concentration
Difficulty making decisions
Speech difficulty
Feelings of unreality/spacey
Other
Feeling tired/lethargic
Dizziness/lightheadedness
Source: From Miller and Mitzel (1995).
27.5 PREVALENCE AND DEMOGRAPHICS
Between 15 and 30 percent of the U.S. population report being "especially" or "unusually"
sensitive to certain chemicals (Table 27.3). Population-based surveys show that approxi-
mately 2 to 6 percent of the general population report physician-diagnosed "multiple chem-
ical sensitivity," "environmental illness," or significant daily impairment from chemical
exposures (Kreutzer et al. 1999, Meggs et al. 1996, Voorhees 1998). Questions used in
these surveys varied, but their findings are strikingly similar.
The largest and best designed of these studies was a 1995 California Department of
Health Services state-wide, randomized telephone interview survey involving more than
4000 people (Kreutzer et al. 1999). The researchers found that 15.9 percent of participants
reported being "allergic or unusually sensitive to everyday chemicals"; 11.9 percent
described sensitivities to more than one type of chemical; and 6.3 percent reported doctor-
diagnosed "environmental illness" or "multiple chemical sensitivity." Female gender and
Hispanic ethnicity were associated with increased self-reporting of sensitivity (adjusted
odds ratios of 1.63 and 1.82, respectively). In contrast with most published clinical studies,
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employment and education were not associated with chemical sensitivity or doctor-diagnosed
MCS, nor were there any associations with marital status, geographic location, and income.
The California study concludes: "Surprising numbers of people believed they were sensitive
to chemicals and made sick by common chemical exposures. The homogeneity of responses
across race-ethnicity, geography, education, and marital status is compatible with physiologic
response or with widespread societal apprehensions in regard to chemical exposure."
Results of several state surveys (California, New Mexico, North Carolina) suggest that
multiple chemical intolerance could be one of the most prevalent, if not the most preva-
lent, chemically related illnesses in the United States (Kreutzer et al. 1999, Voorhees
1998, Meggs et al. 1996). A U.S. EPA survey found that nearly one-third of federal office
workers in mechanically ventilated federal office buildings considered themselves "espe-
cially sensitive" to one or more common chemical exposures (Table 27.3) (Wallace et al.
1993). Notably, rates were similar for complaint and non-complaint buildings.
On average, 80 percent of self-identified MCS patients enrolled in clinical studies have
been women with an average age in the fourth decade and an average educational level of
at least 2 years of college (Fiedler and Kipen 1997b). In contrast, among military and indus-
trial populations, the vast majority of those reporting chemical intolerances are males,
likely reflecting underlying gender ratios (Simon et al. 1990; Miller and Prihoda 1999a,
1999b). In office building situations, the condition is more commonly reported by college-
educated white females of middle to upper-middle socioeconomic status who are in the
midage range (30 to 50 years) (Ashford and Miller 1998). It is not known why more chem-
ically intolerant patients report working in office buildings and service industries, rather
than in heavy industry where exposures to chemicals are more common, nor why more
women than men appear to be sick (Lax and Henneberger 1995, Miller and Mitzel 1995,
Black et al. 1990). The skewed gender ratios may stem from male/female differences in
willingness to report symptoms; something unique about the mixture of indoor air pollu-
tants in a sick building, a setting in which women may be relatively more confined, e.g., as
secretaries; or gender-based biological response differences. The apparent paradox that
fewer multiple chemical intolerance cases arise in heavy industries versus service indus-
tries may be due to: "The healthy worker" selection effect, i.e., workers bothered by chem-
ical exposures tend to migrate to nonchemical jobs; the fact that women, who may be
biologically more vulnerable, are less apt to work in heavy industry, mining, construction,
etc.; or some unknown, but unusually insidious effect of indoor air chemical mixtures.
TABLE 27.3 Frequency of Self-Reported Chemical Intolerance from Several Large Surveys
Those reporting physician-
Those considering diagnosed multiple
Number of themselves especially or chemical intolerance
people unusually sensitive to or daily symptoms
Population studied certain chemicals, % triggered by chemicals, %
EPA office workers 3948 31 Not evaluated
(Wallace et al. 1993)
Rural North Carolinians* 1027 33 3.9
(Meggs et al. 1996)
California residents* 4046 15.9 6.3
(Kreutzer et al. 1999)
New Mexico residents* 1814 17 1.9
(Voorhees 1998)
*Randomdy sampled.
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27.6 SYMPTONS
The vast majority of chemically intolerant individuals report multisystem symptoms
(Table 27.2). Fatigue is the most prevalent complaint. Their symptoms greatly overlap
those of chronic fatigue syndrome and fibromyalgia (Ashford and Miller 1998, Miller
and Mitzel 1995, Chester and Levine 1994, Buchwald and Garrity 1994). Mood changes
(irritability, anxiety, depression) are commonly reported. Exposure-related memory and
concentration difficulties have led teachers, attorneys, executives, nurses, and other
professionals to abandon their cognitively demanding careers.
Different groups with different "initiating" exposures describe strikingly similar symp-
toms: Among 75 chemically intolerant individuals who became ill following building
remodeling and 37 who became ill following exposure to a cholinesterase-inhibiting pesti-
cide, symptoms, ranked in order by severity, were nearly identical (Table 27.2). Central
nervous system symptoms led the list. The most common gastrointestinal complaint was
"problems digesting food." The most frequent respiratory complaint was "shortness of
breath or being unable to get enough air."
Individuals' symptoms are often exposure-specific, e.g., "spaciness" or an upset stom-
ach around diesel exhaust, irritability in the detergent aisle of a grocery store, or confusion
with a particular fragrance. Some patients say the nature of their symptoms helps them
identify a particular trigger (e.g., a pesticide), even when no odor is evident. Individuals
who shared the same initial exposure event (e.g., remodeling of the EPA's headquarters
building-see Case Study 2) may report very different symptoms.
Illness often begins with "flu-like" symptoms, resembling "chronic fatigue syndrome,"
a diagnosis many eventually acquire (Buchwald and Garrity 1994). Awareness of chemi-
cal or food intolerances develops gradually, sometimes accidentally, e.g., following a work
holiday or vacation trip (especially to a relatively clean environment such as the mountains
or seashore). In these situations, the chemically intolerant may become "unmasked." Then
when they return to their workplace or home, their symptoms flare up. After this happens
several times, they begin to suspect environmental causes.
27.7 THE INTERNATIONAL EXPERIENCE WITH
MULTIPLE CHEMICAL INTOLERANCE
Researchers have described this phenomenon-groups of individuals developing multi-
system symptoms and new-onset intolerances following an initial chemical exposure
event-in more than a dozen countries, including the United States, Canada, Australia,
New Zealand, and nine European nations. These groups include: radiology workers from
New Zealand and other nations exposed to x-ray developer solution containing glutaralde-
hyde and other solvents (Genton 1998); federal employees in the EPA headquarters build-
ing in Washington, D.C., exposed to volatile organic chemicals outgassing from new carpet
and construction materials (Hirzy and Morison 1989, EPA 1989); homeowners in Germany
exposed to pentachlorophenol wood preservative used in log homes (Ashford et al. 1995);
sheep dippers in Great Britain exposed to organophosphate pesticides (Ashford and Miller
1998, Monk 1996, Stephens et al. 1995); hospital workers in Nova Scotia exposed to build-
ing air contaminants (Ashford and Miller 1998); casino card dealers in Lake Tahoe,
California, exposed to solvents and pesticides (Cone and Sult 1992); and Gulf War veter-
ans exposed to various chemicals and drugs during military service (Miller and Prihoda
1999a, 1999b; Ashford and Miller 1998; Fiedler et al. 1996b; Miller 1996).
A study comparing European and U.S. experiences with the condition revealed that
"initiating" exposures involving pesticides and solvents were commonly reported on both
_C I- ·- · ·.
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continents (Ashford et al. 1995, Ashford and Miller 1998). There were notable differences
between countries that may inform future studies. For example, pesticides were not impli-
cated in Sweden, Finland, and the Netherlands, where cooler temperatures help control
insects. Organophosphate and carbamate pesticides are frequently cited initiators in the
United States. Those who first become sick after organophosphate or carbamate pesticide
exposures tend to report more severe symptoms, on average, than those exposed to build-
ing air contaminants, suggesting that pesticides in these classes might be especially potent
initiators (Miller and Mitzel 1995).
Organic solvent initiating exposures were reported in all nine European countries sur-
veyed and in North America. Most of these exposures were chronic, involving repeated sol-
vent use, rather than a one-time chemical spill or release. A so-called wood preservative
syndrome, attributed to pentachlorophenol used to preserve logs for homes, appeared only
in Germany (Schimmelpfennig 1994). Notably, sick building syndrome, which is widely
recognized in Scandinavia, has not been associated with cases of multiple chemical intol-
erance there. Perhaps the fact that Scandinavians tend not to use pentachlorophenol or pes-
ticides indoors might explain this. Onset with new carpeting installation has been noted
there; however.
Environmental activism may influence prevalence rates in some countries; however,
similar illnesses appeared in every European country studied (Ashford et al. 1995). The
practice of clinical ecology (Sections 27.2 and 27.11), which began in the United States and
spread to Canada and the United Kingdom, may explain the apparent higher prevalence in
those countries, but it fails to explain the illness' presence in Germany and Holland.
Differences in cultural practices may play a role. In Europe, people tend to spend more time
out of doors, walking to work and shopping, and windows in homes and offices are fre-
quently left open, while in the United States, 90 percent of people spend their day indoors,
often in tightly sealed schools, homes, and office buildings.
Building construction materials and furnishings vary greatly between countries, e.g.,
wall-to-wall carpeting versus washable throw rugs, or no floor covering at all; solid hard-
wood furnishings versus particle board, veneered or pressed wood; varying use of paint,
wallpaper, and adhesive, constituents; and office equipment, including photocopiers, com-
puters, and laser printers. Ventilation practices also differ between countries and cultures.
In North America, tightly constructed office buildings and schools with little or no provi-
sion for fresh outside air have become increasingly common over the past 2 decades.
Chemical use indoors, e.g., pesticides, cleaners, personal care products, fragrances, etc.,
also varies greatly between nations.
27.8 RELATIONSHIP BETWEEN MULTIPLE
CHEMICAL INTOLERANCE AND INDOOR AIR
POLLUTANTS
Indoor air pollutants are among the most frequently cited initiators and triggers for multiple
chemical intolerance. Over the past 2 decades, the condition has become widely known among
indoor air professionals. Proposed explanations for the condition's apparent increase include:
1. The exponential rise since World War II in synthetic organic chemical production and
use (including pesticides), indoors and out, resulting in widespread exposure to novel
chemical species never encountered during human evolution
2. The construction of tighter, more energy-efficient housing, offices, and commercial
buildings, together with decreased fresh outside air supply resulting from energy con-
servation measures during the oil embargo of the mid-1970s
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3. The fact that today more people spend the majority of their day indoors, in buildings or
vehicles, inhaling myriad, low-level volatile organic chemicals
Indoor air pollutants not only appear to set off symptoms in the chemically intolerant, but
several studies suggest that some pollutants or pollutant mixtures may also initiate the con-
dition (Miller and Mitzel 1995; Cone and Sult 1992; Miller and Prihoda 1999a, 1999b).
Indoor air VOC levels tend to be much higher during or soon after remodeling or new con-
struction, by as much as several orders of magnitude, than those later said to trigger symp-
toms. Differentiating between exposures that initiate the process and those that trigger the
first robust symptoms is not always possible. For example, a person might become ill fol-
lowing a pesticide application at home (initiation), but notice the most pronounced symp-
toms with workplace exposures to fragrances, new carpet, paint, particle board, furnishings,
etc., at work (triggering). The former may cause subtle and gradual loss of tolerance; the lat-
ter, robust and immediate symptoms. About 40 percent of chemically intolerant individuals
are unable to recall any initiating events (Fiedler et al. 1996a); others describe a series of
exposures they feel caused stepwise deterioration in their health; and still others report life-
long health problems and intolerances that are exacerbated by indoor air contaminants.
27.9 CASE DEFINITIONS
By definition, a syndrome is "a group of symptoms or signs typical of a disease" (Webster's
1986). Technically, therefore, MCS is not a syndrome: The symptoms patients report are
too heterogeneous. Different organ systems are affected in different individuals. This fea-
ture, more than any other, has encumbered the development of a case definition for the con-
dition. Nevertheless, several consensus case definitions have been proposed that may have
utility for research or medical evaluation purposes, e.g., for compensation (Bartha et al.
1999, NRC 1992, AOEC 1992, Nethercott et al. 1993). Some researchers fear that restrict-
ing the illness' definition to a limited number of symptoms, as has been done for chronic
fatigue syndrome and "Gulf War syndrome," could prematurely constrict the field of view,
thereby excluding from study cases that do not fit preordained criteria. For example, some
proposed MCS case definitions exclude asthma or depression on the grounds that these are
"diagnosable" conditions (Cullen 1987), even though low-level chemical exposures might
cause asthma and depression. There is a consensus that scientifically conducted human
exposure challenge studies (double-blinded, placebo-controlled) are needed to determine
whether chemically intolerant individuals do in fact respond adversely to very low level
environmental exposures, at concentrations well below those affecting most people (NRC
1992, AOEC 1992, Miller et al. 1997).
It appears that other medical conditions may share the same two-step mechanism (initi-
ation and triggering) involved in multiple chemical intolerance (see Sec. 27.10). For exam-
ple, reactive airways dysfunction syndrome (RADS), an asthma-like condition, begins after
a specific, acute chemical exposure; subsequently, bronchoconstriction is triggered by
diverse chemical inhalant exposures. Some researchers think RADS may be multiple
chemical intolerance manifesting in single organ systems, e.g., the lungs (Meggs 1994).
Conceivably, some cases of depression (Rosenthal and Cameron 1991, Bell 1994, Bell
et al. 1992), migraine headaches, attention deficit disorder, panic attacks, seizures, etc.,
might be initiated by acute or chronic chemical exposure and thereafter perpetuated by
everyday, low-level exposures (Ashford and Miller 1998).
Most case definitions proposed for MCS (summarized in Ashford and Miller 1998) echo
the same central observations: chronic, multisystem symptoms triggered by diverse, low-
level chemical exposures, with symptoms resolving when those exposures are avoided.
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A recent paper (Bartha et al. 1999) proposed six "consensus criteria" for MCS, based
primarily on an earlier survey of 89 clinicians and researchers familiar with, but having
divergent views of, the illness (Nethercott et al. 1993). The consensus paper defines MCS as
(1) a chronic condition (2) with symptoms that recur reproducibly (3) in response to low lev-
els of exposure (4) to multiple unrelated chemicals and (5) improve or resolve when inci-
tants are removed (6) with symptoms that occur in multiple organ systems. These same
criteria are encompassed by most proposed research case definitions for MCS. The authors
recommend that MCS be formally diagnosed in addition to any other diagnosable disorders
(e.g., migraine, asthma, depression) in all patients in whom the above six criteria are met and
"no single other organic disorder...can account for all the signs and symptoms associated
with chemical exposure."
Miller and Mitzel (1995) compared symptoms reported by 112 self-identified MCS
patients, 37 who traced their illness to a cholinesterase-inhibiting pesticide exposure and 75
to remodeling of a building. Individual symptom patterns varied, yet, overall, the two expo-
sure groups exhibited statistically similar ordering of symptoms, ranked by intensity. These
findings suggest a shared underlying mechanism or final common pathway for the illness
despite different initiating exposures. A second comparative study of persons with MCS,
Gulf War veterans, and individuals with implants (mostly breast implants) again showed
similar distributions of multisystem symptoms and new chemical, food, and drug intoler-
ances, despite differences in reported initiating exposures (Miller and Prihoda 1999a,
1999b). These studies imply that a wide variety of chemical exposures, whether exogenous
(e.g., chemical spill, pesticide application, indoor air contaminants) or endogenous (e.g.,
implants), might initiate multiple chemical intolerance.
27.10 PROPOSED MECHANISMS
The underlying dynamic remains a mystery. Some physicians and researchers view multi-
ple chemical intolerance as a psychogenic phenomenon resembling depression, somato-
form disorder, or posttraumatic stress disorder. Others see it as a chemically caused medical
illness and propose various physiological explanations (Table 27.4) (for details see Ashford
and Miller 1998, Bell et al. 1992, Bascom 1989, Meggs 1994). To date, surprisingly little
research has been done looking into possible immunological, neurological, inflammatory,
or psychological underpinnings for the condition. Funding for such studies has been scant.
TABLE 27.4 Theories/Mechanisms Proposed to
Explain Multiple Chemical Intolerance
Immune dysfunction or sensitization
Neurological damage or sensitization
Impaired detoxification pathways
Inflammation
Vasoconstriction/vasculitis
Psychiatric or psychological disorders:
An erroneous belief that chemicals are causing illness
Posttraumatic stress disorder
Conditioned behavior (odor conditioning)
Somatoform disorder
Depression
Combinations of the above mechanisms
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As discussed above, researchers have surveyed more than a dozen countries and in each
one have found people who report developing multisystem symptoms and new-onset chem-
ical, food, drug, alcohol, and caffeine intolerances following well-documented exposures,
e.g., to pesticides, indoor air contaminants, or solvents. The fact that these groups, who
share little in common save some initial chemical exposure, all report the same new-onset
chemical, food, and drug intolerances, is a compelling anomaly. Compelling anomalies in
science expose the limitations of old paradigms and drive the search for new ones.
Although the symptoms associated with multiple chemical intolerance are too diverse for
it to be a single syndrome, it is possible that what we are dealing with is an entirely new
class of diseases. The germ theory and the immune theory of disease also arose out of a
need to explain certain anomalous observations. These theories took seemingly unrelated
illnesses involving different organ systems, myriad causal agents, and different specific
mechanisms and collapsed them into a single general mechanism that fit the observations
of reliable observers and just made sense. Fever, the hallmark symptom for infectious dis-
eases, may have its parallel in the new-onset chemical intolerances that mark these ill-
nesses, all of which appear to share the same general mechanism, here referred to as
toxicant-induced loss of tolerance (TILT) (Miller 1997, Ashford and Miller 1998, Newlin
1997). Exposures causing TILT, e.g., pesticides, solvents, or combustion products, may be
acting via different specific mechanisms and affecting different target organs (Fig. 27.1),
as is the case for different infectious diseases, e.g., cholera, AIDS, and shingles.
TILT appears to involve two steps (Fig. 27.2) (Ashford and Miller 1998, Miller 1997):
(1) First, a single high-level exposure or repeated lower-level exposures to pesticides, sol-
vents, indoor air contaminants, etc. cause loss of tolerance in a subset of those exposed
(initiation); (2) thereafter, low levels of common substances-chemicals, foods, medica-
tions, alcoholic beverages, and caffeine-set off multisystem symptoms, thus perpetuating
illness (triggering).
Ear, Nose and Throat
* sinusitus
* polyps
* tinnitus
* recurrent otitis
Miscellaneous
* Chronic Fatigue Syndrome
· Implant syndromes
* "Gulf War Syndrome"
Skin
* eczema
·hives Cot
· other rashes,
eruptions
Neuropsychological
* Multiple Chemical Sensitivity
* Attention Deficit Hyperactivity
Disorder (ADHD)
* depressionlmanic-depression
* migraines and other headaches
· seizures
TOXICANT-INDUCED
LOSS OF
TOLERANCE
inective Tissue/Musculoskeletal
fibromyalgia
carpal tunnel syndrome
temporomandibular joint
dysfunction (TMJ) syndrome
arthritis
lupus
Cardiovascular
* arrhythmias
* hypertension
*  hypotension
* Raynaud's phenomenon
Respiratory
* asthma
Reactive Airways Dysfunction
Syndrome (RADS)
* toluene diisocyanate
(TDI) hypersensitivity
K Gastrointestinal
* Irritable bowel
* reflux
FIGURE 27.1 Conditions that may result from toxicant-induced loss of tolerance. Illnesses like depression,
migraine, arthritis, and chronic fatigue may have various underlying mechanisms, one of which might be TILT.
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FIGURE 27.2 Phenomenology of toxicant-induced loss of tolerance (TILT). Illness appears to develop in
two stages: (1) initiation, i.e., loss of prior, natural tolerance resulting from an acute or chronic exposure (pes-
ticides, solvents, indoor air contaminants, etc.), followed by (2) triggering of symptoms by small quantities
of previously tolerated chemicals (traffic exhaust, fragrances), foods, drugs, and food/drug combinations
(alcohol, caffeine). The physician sees only the tip of the iceberg-the patient's symptoms-and formulates
a diagnosis based on them (e.g., asthma, chronic fatigue, migraine headaches). Masking hides the relation-
ship between symptoms and triggers. The initial exposure event causing breakdown in tolerance also may go
unnoticed. (DUTHSCSA 1996.)
Which inhalants, foods and drugs trigger symptoms varies from case to case. Many
affected individuals say that continued exposure expands their circle of intolerances, a phe-
nomenon referred to as "spreading." Symptoms are exposure-specific and highly individual.
For example, one person might experience headaches with diesel exhaust, mental confusion
with a certain fragrance, or nausea with cashews. The effects of a single exposure may last for
hours. Thus, a person who uses hairspray or fragrances in the morning, cooks breakfast on a
gas stove, and then drives through heavy traffic to work in a sick building may experience
near-continuous symptoms that overlap in time, creating a kind of background symptom noise
that hides or "masks" the effects of single exposures (Miller 1996, 1997). Repeated daily
exposure to the same trigger, whether office air contaminants or caffeine, appears to result in
habituation, with symptoms becoming chronic in nature. Masking and habituation tend to blur
the symptom-exposure relationship so that physicians, and even the patients themselves, may
fail to recognize triggers. "Withdrawal-like" symptoms may occur when exposures are inter-
rupted (e.g., over a weekend) with symptoms becoming robust with reexposure following a
period of avoidance, e.g., Monday morning on return to work. Masking may explain the day-
to-day variations in symptom intensity most affected individuals initially report.
Converging lines of evidence support TILT as a general mechanism underlying this illness:
1. Similar multisystem symptoms and new-onset intolerances reported by researchers
among different demographic groups from more than a dozen countries following well-
defined exposures to pesticides, solvents, indoor air contaminants, etc.
------------------L ----
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2. The fact that these new-onset intolerances are not limited to chemical inhalants but also
involve foods, caffeine, alcohol, medications, and skin contactants.
3. The striking parallels between this condition and addiction (see below) suggesting
related neural mechanisms (Randolph and Moss 1980, Miller 1997).
4. The identification of an anatomical substrate-the nervous system-whose malfunc-
tion could explain these problems,
5. Recent animal models replicating features of TILT (Overstreet et al. 1996, Sorg 1996,
Rogers et al. 1999).
Randolph was first to describe the striking resemblance between chemical intolerance
and drug addiction. Both are characterized by stimulatory and withdrawal symptoms, crav-
ings, and cross-addiction/intolerances to structurally diverse substances. One theory is that
both addiction and chemical intolerance (or "abdiction") might result.from loss of tolerance
due to repeated exposure to drugs or pollutants, leading to an amplification of stimulatory
and withdrawal symptoms. Addicts become addicted, in part, in order to avoid unpleasant
withdrawal symptoms. In contrast, chemically intolerant individuals who recognize spe-
cific triggers tend to avoid those triggers, but for the same reason addicts remain addicted-
in order to avoid unpleasant withdrawal symptoms. Initially, many chemically intolerant
individuals consume caffeine and have no idea that it bothers them. In fact, they may expe-
rience a brief lift from it, while overlooking the caffeine withdrawal headaches they
develop several days later. These apparent polar opposites-addiction and abdiction-thus
could be mirror-image strategies for avoiding withdrawal symptoms resulting from TILT
(Newlin 1997, Miller 1996, 1999).
Specific physiological mechanisms that might explain TILT and multiple chemical
intolerance include olfactory-limbic kindling (sensitization of the nerve pathways that lead
from nose to brain) (Bell et al. 1992), other neural sensitization processes (Sorg 1999), neu-
rogenic inflammation (Bascom 1991, Meggs and Cleveland 1993), genetically based or
chemically induced cholinergic supersensitivity (Overstreet et al. 1996), and metabolic dif-
ferences, e.g., decreased sulfation capacity (McFadden 1996), abnormal porphyrin metab-
olism (Morton 1995), or paraoxonase deficiency (organophosphate detoxifying enzyme)
(Costa et al. 1999, Haley et al. 1999).
Proposed psychological mechanisms include odor conditioning, physician-induced
(iatrogenic) beliefs, panic disorder, toxic agoraphobia, posttraumatic stress disorder (e.g.,
illness resulting from a traumatic chemical spill or childhood sexual abuse), somatoform
disorder, and depression (Binkley and Kutcher 1997; G6the et al. 1995; Gots 1995;
Guglielmi et al. 1994; Kurt 1995; Pennebaker 1994; Simon 1994; Sparks et al. 1994a,
1994b; Spyker 1995; Staudenmayer et al. 1993; Staudenmayer and Selner 1987;
Staudenmayer 1999). Carefully conducted studies are needed to untangle this confusion of
competing hypotheses.
Persons who develop chemical intolerances following an "initiating" exposure some-
times suffer from health problems that preceded the "initial" exposure event. Aerospace
workers whose chemical intolerances began after a new composite plastic was introduced
in a workplace process averaged 6.2 unexplained physical symptoms which preceded the
change in process, versus 2.9 unexplained symptoms in unaffected coworker controls
(Simon et al. 1990) (see Case Study 3). Fifty-four percent of the chemically intolerant
workers had a history of anxiety or depression that preceded their exposure, versus 4 per-
cent of controls. Other researchers find that past psychiatric illness does not explain the ill-
ness (Fiedler et al. 1992). Even for chemically intolerant individuals who have a history of
depression predating their "initiating" exposure, the question remains whether their intol-
erances are due to depression, whether they may be more vulnerable to developing intoler-
ances because of preexisting depression (altered brain neurochemistry), or whether their
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preexposure depression was itself due to prior, unidentified intolerances (Davidoff and
Fogarty 1994).
Some researchers have concluded the condition must be psychogenic because it runs
counter to accepted disease mechanisms. Davidoff and Fogarty (1994) examined 10 pub-
lished studies that explored possible psychogenic theories for chemical intolerance. All
were found wanting: In these studies, scientifically unsupportable conclusions concerning
cause-and-effect were drawn, and psychological symptoms were erroneously assumed to
be psychogenic when chemical exposures might also explain them. The study designs
failed to exclude physiological mechanisms. Future studies need to be designed to distin-
guish between competing hypotheses.
27.11 MEDICAL EVALUATION AND TREATMENT
"Clinical ecologists," who today call themselves "environmental physicians," are the
physician group historically most sympathetic to this illness. Some worked earlier as aller-
gists, otolaryngologists, etc. before joining the ecologists. Various professional medical
societies, especially the allergists, have been critical of the ecologists' claims, and have
published position papers critical of their theories and practices, citing the anecdotal nature
of their studies, an overreliance on self-reported symptoms, and their "unproven" diagnos-
tic and treatment practices, such as sauna therapy, vitamin and mineral supplements, and
provocation/neutralization (subcutaneous injection or under-the-tongue administration of
dilute foods and chemicals for testing and treatment). Clinical ecology has been labeled
"junk science," and a "medical subculture," the patients as "true believers," and the whole
phenomenon as "An unnecessary burden perpetrated on society.. .tantamount to organized
crime" (Staudenmayer 1999, Brodsky 1987, Staudenmayer and Selner 1987, Huber et al.
1992). Some see these attacks on the ecologists as "killing the messenger," using the lack
of evidence of theraputic effectiveness not only to reject their unorthodox approaches, but
also to reject the legitimacy of the condition.
There is no established or even widely accepted medical treatment for multiple chemi-
cal intolerance at this time. A multifaceted approach, components of which include the
identification and avoidance of chemicals and foods that trigger symptoms, low- or no-cost
alterations of patients' physical environments, and psychological support, as appropriate,
has the potential to alleviate suffering and prevent worsening of the condition.
In the United States, affected individuals must chart their own course to recovery.
Obtaining balanced information and medical help from informed and receptive physicians
is difficult. Patients' memory and concentration problems interfere with care seeking,
making lifestyle changes, obtaining social support services, etc. difficult, especially in the
absence of good family support. Many individuals seek assistance from federal agencies.
However, the Environmental Protection Agency (EPA), the Agency for Toxic Substances
and Disease Registry (ATSDR), the National Institute of Environmental Health Sciences
(NIEHS), the National Institute for Occupational Safety and Health (NIOSH), and various
state agencies provide no clear path for obtaining answers or assistance. Canada alone has
two government-sponsored clinics devoted to chemical intolerance research and patient
evaluation. Comparable facilities are not available in the United States or elsewhere
(Ashford and Miller 1998).
Chemically intolerant patients often deplete their financial resources and energies
consulting dozens of specialists and trying a host of unproved treatments. In one study,
40 percent had consulted at least 10 medical practitioners (Miller and Mitzel 1995). The
average patient makes 23 health care provider visits per year (Buchwald and Garrity
1994). The practitioners they see often have never heard of the condition and little train-
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ing is available through medical schools or professional conferences. Various national
patient support groups offer counsel free to patients, referring them to sympathetic physi-
cians, attorneys, etc.
Busy doctors seldom take occupational or environmental histories, even when circum-
stances warrant (IOM 1995). These histories are time-consuming and physicians may be
unable to interpret the information they do receive. Potentially important exposures may
be missed or dismissed, e.g., recent remodeling, pesticide use. Specialists who focus on
single organ systems tend to underestimate the illness' full impact. As a result, chemically
intolerant patients migrate from physician to physician accumulating personalized sets of
diagnostic labels-organic brain syndrome, chronic fatigue syndrome, psychosomatic
disease, migraines, fibromyalgia-unaware of the underlying dynamic. Patients often
become angry with and try to avoid doctors they find skeptical or ill-informed, especially
since physicians render professional opinions that bear heavily on insurors' determina-
tions, compensation boards, and disability reviewers, as well as the views of employers,
friends, and family.
Physicians need to ask about and document chemical, food, drug, alcohol, and caffeine
intolerances these individuals may have experienced, both before and since the
putative initiating exposure. Self-administered questionnaires, e.g., the 50-item Quick
Environmental Exposure and Sensitivity Inventory (QEESI) (see appendix at the end of
the chapter), can speed this process (Miller and Prihoda 1999a, 1999b). The QEESI con-
tains five scales that allow patients to self-rate their symptoms, chemical intolerances,
other intolerances (foods, drugs, alcohol, caffeine, skin contactants, pollens, dust, molds),
life impact, and masking (i.e., ongoing exposures that may hide the symptom-exposure
relationship). These scales have been shown to exhibit good reliability, validity (i.e., they
correlate well with standard health status and life function measures), sensitivity (92 per-
cent) and specificity (95 percent) (Miller and Prihoda 1999a, 1999b). This screening ques-
tionnaire takes only 10 to 15 minutes to complete and can be administered at intervals to
monitor progress. The QEESI might also help indoor air consultants identify more vul-
nerable building occupants and tailor indoor air interventions accordingly. A workplace
physician, nurse, or industrial hygienist could also provide the QEESI to individuals who
report building-related health problems.
Physicians may be hesitant to diagnose multiple chemical intolerance even when they
feel this label best fits the patient's situation. They tend to use "piecemeal," but widely
accepted, diagnoses with compensable diagnostic codes, e.g., asthma, toxic encephalopa-
thy, or migraine headache. Workers' compensation boards and insurance companies often
challenge a multiple chemical sensitivity diagnosis, undermining physicians' willingness
to use it. In contrast, toxicant-induced loss of tolerance, which describes the underlying
mechanism-the breakdown in tolerance resulting from exposure that has been reported
by reputable scientists in numerous, peer-reviewed medical articles, has not yet been scru-
tinized or challenged in this manner.
It is the responsibility of health care providers to discuss TILT with their patients when
symptoms and circumstances warrant. Which symptoms? Fatigue, memory and concen-
tration difficulties, mood changes, and multisystem health problems. The more organ sys-
tems are affected, the more practitioners should entertain this possibility (recalling that
when the illness begins, only a single organ system may be involved). What circumstances?
If symptoms develop in the aftermath of an exposure to solvents, pesticides, a sick build-
ing, remodeling, or new construction; if a sudden, major change in an individual's health
has occurred; if clinical laboratory abnormalities (e.g., pulmonary function tests) appear
after the exposure and/or improve with avoidance and/or worsen with reexposure; if others
who share the same initial exposure became ill at about the same time, particularly if they
manifest multiple symptoms and intolerances; and if formerly well-tolerated exposures-
chemicals, foods (or feeling ill after meals or if a meal is missed), medications, alcohol, or
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caffeine-now set off symptoms. New-onset depression, asthma, severe headaches, etc., in
the absence of other clear causes, should invite inquiry as to whether chemical intolerance
might be involved. None of the above factors alone "proves" anything, but the more that
fit, the more the practitioner should suspect TILT.
Under circumstances like these, a practitioner needs to help patients understand the
divergent opinions about this illness in the medical community, explore available treatment
options, including psychological therapies, social support interventions, and avoidance
strategies, being mindful that the efficacy of any treatment for this condition remains
unproved, and help patients understand that the underlying mechanism remains a mystery
and that no test is diagnostic of the problem.
The value of a careful exposure history cannot be overemphasized. Patients can be
instructed to draw their own symptom/exposure timelines: Symptoms and medical prob-
lems are recorded across the top of the line, and lifetime events (e.g., changes in jobs, res-
idences, military service, surgeries, pregnancies, remodeling, pesticide use, etc.) along the
bottom. A clear, concise chronology, preferably in this format, can bring into clearer focus
potential contributory exposures.
A comprehensive physical examination is essential, even though findings are frequently
negative or not diagnostic. Routine baseline laboratory tests may be helpful, e.g., a com-
plete blood count and chemistry profile, as well as specific tests suggested by symptoms or
physical findings, e.g., thyroid function tests, pulmonary function testing, autoimmune
markers, neuropsychological testing, etc. (Weaver 1996). Blood tests for environmental
chemicals should be ordered only when specific exposures are suspected and the substance
is not rapidly metabolized or excreted. Biological specimens can confirm exposure to chlo-
rinated pesticides or recent exposure to cholinesterase-inhibiting (organophosphate or car-
bamate) pesticides, but generally are not helpful for exposures to most solvents, indoor air
VOCs, or cholinesterase-inhibiting pesticides months after an acute pesticide exposure. To
date, no single, consistently abnormal immunological parameter has been demonstrated in
these patients.
Various atypical laboratory findings have been reported in these individuals, including
abnormal T and B lymphocyte counts; helper/suppressor T cell ratios; immunoglobulin
levels; autoimmune antibodies (e.g., antinuclear, antismooth muscle, antithyroid, anti-
parietal cell); activated T lymphocytes (TA I or CD26); quantitative EEGs; evoked poten-
tials; SPECT and other brain scans (Heuser and Mena 1998, Hu 1999, Mayberg 1994,
Ross et al. 1999); vitamin, mineral, amino acid, and detoxification enzyme levels; and
blood or tissue levels of pesticides, solvents, and other chemicals. Study flaws vary, but
include the failure to define the study population (no case definition used); to compare
cases with age- and sex-matched controls; to blind specimens so that those performing the
analyses are unaware of whether samples came from patients or controls; and to document
the test method's accuracy and reproducibility. Some proponents for the illness claim that
different immunological abnormalities occur in different patients. However, if enough
tests are done, statistically a certain number will be abnormal (e.g., 1 in 20), a fact fre-
quently forgotten.
There is an emerging consensus that "in cases of claimed or suspected MCS, complaints
should not be dismissed as psychogenic and a thorough work-up is essential" (EPA 1994).
Recognition of chemical intolerance as a disability under the Americans with Disabilities
Act (ADA) likewise is growing (see below). Employers who dismiss the condition out-of-
hand because of the medical uncertainties surrounding it, or on the basis of their own hunch
that it does not exist, leave themselves open to litigation (Winterbauer 1997).
Among treatments patients have tried, the one they most consistently report as helpful
is identifying and avoiding their chemical and food triggers (Johnson 1996, LeRoy et al.
1996, Miller 1995). In one study, 97 percent of 112 chemically intolerant individuals
reported major food intolerances (Miller and Mitzel 1995). The occupational medicine doc-
·py ---
27.18
MULTIPLE CHEMICAL INTOLERANCE AND IAQ
tors these patients see are unlikely to attempt food elimination diets. It simply is not part of
their training. On the other hand, allergists, who may use elimination diets, often feel ill-
prepared to evaluate the patients' chemical exposure concerns. As a result, these patients
tend to "fall in the crack" between these two specialties. Inadequate reimbursement for the
physicians who see them, the complexities of medical management, and frequent involve-
ment in compensation and litigation have not helped their popularity as patients.
Compounding these difficulties, chemically intolerant patients frequently report
adverse reactions to drugs (prescription and over-the-counter) (Miller and Prihoda 1999a).
Many either avoid drugs altogether or use reduced doses if possible. Drug side effects, even
with standard dosing, and frequent unusual or idiosyncratic reactions frustrate physicians
and patients alike (McLellan 1987).
The condition disrupts careers, families, and social lives. Psychological support (to be
distinguished from traditional psychotherapy) can be an important therapeutic adjunct irre-
spective of whether the condition is psychogenic or physical in origin, and may be provided
by psychologists, psychiatrists, social workers, or primary care doctors. Some patients have
found psychological support "very helpful," although most report that psychological inter-
ventions do little to alleviate their responses to chemicals (Miller 1995). Claims that cer-
tain psychological and psychiatric interventions are effective are strictly anecdotal
(Amundsen et al. 1996, Bolla-Wilson et al. 1988, Guglielmi et al. 1994, Schottenfeld and
Cullen 1985, Spyker 1995). No studies comparing the efficacy of exposure avoidance ver-
sus psychological/behavioral interventions have been conducted. Some authors have touted
psychological interventions as the preferred or only acceptable treatment modality (Sparks
et al. 1994b). Given the uncertainties concerning the origins of this condition, these rec-
ommendations are at best premature and, at worst, potentially harmful (Miller 1995).
Multiple chemical intolerance is increasingly being recognized as a disability (Winter-
bauer 1997). Internal memoranda of the Social Security Administration and Department of
Housing and Urban Development recognize the illness for purposes of compensation and
housing accommodation, respectively. The most recent available statistics from the Equal
Employment Opportunity Commission (EEOC) indicate that from November 1, 1993,
through September 30, 1998, 465 MCS discrimination-related complaints were filed, 60
percent of which alleged failure of the employer to provide reasonable accommodation and
47 percent of which alleged wrongful discharge (EEOC 2000). MCS complaints have a
lower resolution rate (39.9 percent) than other discrimination complaints (81.2 percent)
(EEOC 2000).
The courts have struggled over whether the illness should be viewed as a disability, issu-
ing conflicting opinions. Current law would make it difficult for an employer to claim that
a condition that so greatly restricts daily activity is not a disability (Winterbauer 1997). The
Americans with Disabilities Act obligates employers to seek inexpensive, practical solu-
tions that will reduce troublesome exposures (for a detailed discussion of the ADA and its
applicability to MCS, see Winterbauer 1997). It does not require that a chemical-free work-
place be provided.
Few affected by this illness report full recoveries, even decades after it develops. There
are those rare individuals whose illness was recognized at an early stage, who avoided addi-
tional exposure, and who appear to have recovered (see Case Study 4) (Hileman 1991). Early
recognition and exposure avoidance thus may have the potential to prevent permanent, dis-
abling illness. Treating the illness once it is entrenched is difficult, underscoring the impor-
tance of prompt intervention and exposure avoidance. Physicians and indoor air specialists
need to watch for individuals manifesting multiple symptoms and intolerances who may have
ongoing exposures to pesticides, remodeling, solvents, etc., and who may be in the initiation
phase of the illness. Removal from suspect exposures for 7 to 10 days on a trial basis may be
diagnostic, as well as therapeutic. If improvement occurs, and symptoms not so severe as to
preclude it, judicious reexposure under a physician's watchful eye may be illuminating.
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Some patients have been able to continue to work, provided they avoid exposures
that bother them. Successful workplace accommodations (see Sec. 27.12) have included:
increasing fresh air supply and air circulation, removing business machines (fax machines,
copiers, laser printers) from the immediate work environment, providing an alternate work
space, removing carpeting, selecting odorless and less toxic cleaning agents, adopting inte-
grated pest management, and allowing employees to work from home (Table 27.5).
27.12 ENVIRONMENTAL EVALUATION AND
INTERVENTION
Indoor air quality consultants experienced in dealing with multiple chemical intolerance
can be helpful in identifying sources and low-cost solutions during an initial walk-through
survey. These individuals need to be nonsmokers with an excellent sense of smell,
enabling them to track down potential contributory sources, e.g., building materials, fur-
nishings, office equipment, and cleaners. Molds also release VOCs that may trigger symp-
toms and, conceivably, even initiate the illness. Water leaks, water damage, musty odors
or visible mold call for immediate corrective action in any building, no matter how hardy
its occupants.
The chemical concentrations that trigger symptoms in these individuals appear to be
orders of magnitude below OSHA standards. Unless OSHA limits are exceeded, which will
rarely be the case, such standards have no relevance in these situations and should not
be invoked nor used as a benchmark for safety. Not infrequently, building owners hire
consultants who conduct extensive, expensive air sampling, hoping to assure occupants the
Case Study 4. Improvement in Chemical Intolerance After Early Intervention
A 50-year old pharmacology professor developed facial itching and eye irritation, which bothered
him whenever he worked in his small, windowless university office that was stacked floor-to-ceiling
with books, papers, and files. Reading new journals and certain books made his eyes water. He felt
better when he worked in the adjoining laboratory, despite its chemicals and solvents, so he moved
in there. At home, he took all of his papers and books down to the basement. Despite these mea-
sures, his symptoms persisted. He started to notice that the Sunday paper had a pronounced odor and
made his eyes water.
Weeks later, he became aware of burning and stinging of his face and inner eyelids when he
tried to assemble cardboard file folders or examine freshly developed photographs. A physician
suggested to him that he might be suffering from multiple chemical intolerance, and advised him
not to touch paper and to air out newly printed materials before reading them. Still, the odor of
newspapers became so objectionable that he could not be in the same room with one. Simply walk-
ing past a bookshelf full of books set off his symptoms. He resorted to wearing goggles, a face
shield, gloves, and a respirator with formaldehyde and VOC absorbent cartridges, and used a desk
fan whenever he worked with papers.
His intolerances spread further to include scented soaps, aftershaves, cosmetics, and lotions
worn by others. These irritated his upper airway, and caused coughing, chest pain, and difficulty
breathing. Carbonless copypaper, new permanent-press pants, automobile interiors, the subway,
gasoline, enclosed malls, clothing aisles, his gas stove, felt-tip pens, carpeted areas, and his com-
puter's exhaust also triggered symptoms. He went to see a second physician who recommended
that he avoid unnecessary irritant exposures, which he did. Within a month, his symptoms began
to improve. Subsequently, he learned that the exhaust vent to his office had been shut off during
some repairs and never reopened. Nearly a year after he had first become ill, he was able to return
to his laboratory, use solvents, and read new journals with only minor difficulty (Hileman 1991).
---- - - - ---------- - ·------- ---------- ·0--- --- -- -I--
27.20
MULTIPLE CHEMICAL INTOLERANCE AND IAQ
TABLE 27.5 Strategies for Accommodating Chemically Intolerant Individuals
Adopt a fragrance-free workplace policy, asking that no scented products be worn during work
hours. Some organizations have adopted dress codes that discourage fragrance use. Others post
signs. Under no circumstances should affected individuals be named in memos or signage. Many
people do not realize that shaving lotions, aftershaves, fabric softeners, deodorants, hairspray, and
handcreams commonly contain fragrances; they need to know that even the fragrances they most
enjoy wearing contain VOCs that may be noxious to others. Fragrances are readily transferable
from hands to papers, posing a potential problem for highly susceptible individuals. Hospitals,
especially, should be fragrance-free. Patients suffering from asthma, migraine headaches, nausea
(e.g., individuals undergoing chemotherapy), not just multiple chemical intolerance, often are
bothered by odors. The Mayo Clinic in Scottsdale, Arizona, discourages fragrance use by staff
with a statement in its dress and decorum policy and quarterly newsletter reminders to employees:
"Perfume Usage-for the consideration of patients and co-workers, please do not use heavily
scented perfumes and colognes. Patients as well as employees may be allergic to certain scents,
and heavy perfume/cologne usage can cause them discomfort or make them ill."
Fragrance sprays and dispensers in restrooms, and scents or "air fresheners" dispensed auto-
matically into the air or ventilation system, need to be eliminated. Unscented, nonodorous
cleaning agents are preferred for restrooms, floors, and other surfaces. If restrooms are properly
cleaned and ventilated, air fresheners should not be needed to mask odors. Note: The University
of Minnesota's School of Social Work has a fragrance-free policy for offices and classrooms.
Signs alert visitors: "Some persons employed or studying in the School of Social Work report sen-
sitivities to various chemical-based or scented products. We ask for everyone's cooperation in our
efforts to accommodate their health concerns." Several California cities have adopted fragrance-
free resolutions or policies, in order to improve access to public events and facilities for the
chemically intolerant.
· Modify or relocate the affected individual's work space so as to increase fresh air ventilation and
reduce troublesome exposures. Other potentially helpful strategies include: Openable windows,
fresh air exchangers, and/or adequately sized air filtration units with filter media for particulates
and vapors; eliminating odorous furnishings, e.g., carpet, particle board furniture, or odorous
veneers, laser printers, copiers, carbonless copypaper (some brands may be better tolerated); and
placing personal computers and printers in ventilated enclosures with glass fronts. Metal desks
and shelving may be preferable to veneers or particle board. Some employers have assigned an
assistant to chemically intolerant employees to help with photocopying, entering problem areas,
etc. In a few cases, state disability funds have paid for assistants.
* Provide personal protective equipment, e.g., face masks with appropriate filters, for meetings or
other short-term exposures.
* Notify susceptible individuals in advance about maintenance activities that may pose a problem
for them. Provide schedules for cleaning, extermination, floor waxing, repair and construction
work, landscape chemical applications, or mowing. Alternatively, schedule these activities while
affected employees are away from the building. Offer temporary, alternative work arrangements,
e.g., during carpet cleaning, painting, or pesticide application, until employees can reenter the
space without experiencing symptoms.
* Select the least toxic, most odor-free construction and maintenance supplies. Affected individuals'
advice should be sought when choosing paint brands, cleaning products, whiteboard markers, new
furnishings, etc.
* Eliminate, or at least minimize, pesticide use indoors and out. Lawn treatment chemicals, herbi-
cides, etc., can migrate indoors via air intakes, cracks, and crevices (consider how a skunk's
odor seeps indoors even when windows are closed). Use integrated pest management (IPM),
applying pesticides only when non- or less-toxic approaches fail. IPM emphasizes improved
sanitation, mowing, insect traps, baits, and sealing crevices and openings (for one university's
experience with a pest control policy to protect the chemically intolerant, see Brown 1999). If
pesticides are needed, then select the least toxic, least volatile, and least persistent formulation
that will still work.
· ICI-r_ll_ ------ ·I ----- ·- ·LII C1 - -- .
27.21
HUMAN RESPONSES
TABLE 27.5 Strategies for Acconummnodating Chemically Intolerant Individuals (Continued)
* Allow affected individuals to adopt flexible schedules and even work from home. Certain jobs
permit flexible work hours, enabling chemically intolerant individuals to avoid traffic and traffic
exhaust, or customers or coworkers wearing fragrances. Telemarketing, writing, or computer
assignments may lend themselves to work-at-home arrangements. Employers need to ensure that
such off-site employees know their assignments, function as full partners in the workforce, and are
eligible for awards and other perquisites.
* Educate the entire workforce. All coworkers, custodial staff, maintenance personnel, etc. must
receive instruction concerning the nature of the disability. This is essential for enlisting coworkers'
support (e.g., for fragrance-free policies), and avoiding stigmatization or harassment of those
affected. Coworkers need to understand that chemically intolerant individuals may appear well
and occasionally be seen in restaurants, movie theaters, or hair salons, or working on their car
without obvious difficulties, but that their health may be jeopardized by certain exposures.
Managers need to show that they take the illness seriously and explain the protective actions being
taken. A positive, proactive approach will prevent grumbling or unkind remarks or actions by
coworkers. An appropriately phrased memo may preempt inconsiderate behavior by others, e.g.,
deliberate perfume use or spraying of fragrances on the affected individual's chair or telephone,
actions that potentially could expose the employer to a harassment suit.
building is safe. The obliging consultant's report finds that exposures in the building are well
below OSHA limits-an uninformative and potentially disastrous conclusion. Affected
occupants are apt to see this as management's discounting their symptoms or questioning
their veracity. Compensation claims and litigation can be the unfortunate result.
Environmental interventions for the chemically intolerant target three building occu-
pant groups: (1) those who are healthy, but if exposed, may be at increased risk for devel-
oping the illness; (2) individuals who show early signs of TILT, e.g., those whose
symptoms persist hours or days after they leave the building and/or who are beginning to
develop new intolerances; and (3) those with the full-blown condition. Protective measures
directed at these groups involve: (1) prevention; (2) early intervention; and (3) accommo-
dation, respectively.
Achieving good indoor air quality draws on the entire compendium of strategies in this
handbook-the use of nonoutgassing construction materials and furnishings, sufficient
fresh makeup air, moisture control, proper HVAC maintenance, etc. Protecting the most vul-
nerable occupants should provide a margin of safety for others. Intervention during the ill-
ness' initiation phase has the potential to halt or even reverse its course (see Case Study 4).
Like the proverbial canary in a coal mine, these individuals may be sentinels for building
exposures that could be affecting others to varying degrees, e.g., causing eye irritation or
lowering productivity. Illness recognition may occur in the workplace or a doctor's office.
An employer's industrial hygienists and physicians are best positioned to recognize symp-
toms associated with workplace exposures. The QEESI (Sec. 27.11 and appendix to the
chapter) can help affected individuals understand their condition better, enabling them to
recognize triggers at work and at home, e.g., household extermination, hobby exposures, or
home remodeling. At the present time, early recognition and prompt removal from exposure
offer the most promise for reversing the condition.
Once the illness progresses beyond a certain point, no current medical treatment reliably
reverses it. For this reason, it is crucial to respond to complaints immediately and to act
quickly to resolve the problems. Frequently, an individual can be moved to another area or
allowed to work at home temporarily to prevent worsening illness and disability, while
management determines, preferably with the help of the affected individual and perhaps the
physician, what actions are needed to remediate the problem. Accommodating chemically
"I ·I ------ --- · . -
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intolerant individuals in the workplace is challenging. There are some low-cost interventions.
An ongoing partnership between the affected person(s), management, personal physicians,
the company's health professionals, industrial hygienists, building engineers, and mainte-
nance staff should be established. Single interventions rarely are curative. More often, a trial-
and-error process over an extended period, e.g., weeks or months, is required. Not every
intervention will work. Installing an openable window might bring in exhaust from idling
vehicles or buses. Moving the workstation away from copier machines and coworkers' fra-
grances will not be helpful if the new workstation is next to a restroom orjanitor's closet.
People who are chemically intolerant fear being singled out or considered workplace
troublemakers. Many simply suffer silently. If they appear well, coworkers may assume
incorrectly that things are fine. Continued exposure, however, may jeopardize their health,
as well as the health of others. Individuals who have had the condition for years are often
the best source of information concerning what corrective measures may be beneficial.
Some patient support and advocacy groups work willingly with employers and employ-
ees to help identify cost-effective interventions. The director of one group, the National
Center for Environmental Health Strategies, has served on federal advisory committees for
housing and employment accommodations under the Fair Housing Act and the Americans
with Disabilities Act (Lamielle 1999). Employers tend to steer clear of these groups for fear
they may demand chemical-free workspaces. Reportedly, this is not the case. Neither is it
incumbent on an employer to adopt these groups' recommendations. Rather, "to some
degree, the employer's choice is between learning what these sources have to say at the out-
set of the accommodation process or in the middle of a trial" (Winterbauer 1997). Seeking
advice from support groups demonstrates both a good faith effort and that the employer
considers the employee inherently reasonable. Many employers have successfully accom-
modated chemically intolerant individuals, thereby retaining productive, loyal, and grate-
ful employees (Miller et al. 1999, Brown 1999) (see Case Study 5).
Case Study Number 5. Workplace Accommodation for Multiple Chemical Intolerance
Three women with multiple chemical intolerances learned that the government agency they
worked for was about to move to a new office building. In response to their concerns, an industrial
hygienist conducted baseline air sampling just prior to move-in. Total VOC concentrations of 200
Lg/m3 (toluene equivalent units with chemical constituents) were found (Miller et al. 1999). Soon
after the move, all three women reported worsening of their symptoms, including severe asthma,
seizure-like activity, headaches, irregular heart beat, feelings of drunkenness, unsteadiness, light-
headedness, cognitive difficulties, irritability, fatigue, and skin burning and redness, and worsen-
ing and/or spreading of their intolerances to chemicals associated with new construction, vapors
from copier machines and fax machines, perfumes, and insecticides.
One woman who experienced balance problems and light-headedness in the new office build-
ing, ended up transferring to an older building and finally had to work from home. Another who
became ill also left the building, but was able to return when an air cleaner equipped with char-
coal/high-efficiency particulate filters was installed in her office. The third woman was able to work
normally in the building, but only after it had outgassed for a year. One year postconstruction, a
fourth chemically intolerant woman came to work in the same building. She experienced no major
difficulties in the building, however, outside of work she noticed having reactions to perfumes, vehi-
cle exhaust, petroleum and paint vapors, tire stores, carpeting, pet supplies, and insecticides.
One of the women reported having been chemically intolerant all her life. The others said they
became sick after staying in a new motel room, working with laboratory solvents, or during new
home construction. Workplace accommodations included scheduling maintenance activities while
the women were away and providing respirators as needed (Miller et al. 1999). None of the other
building occupants reported developing chemical intolerances, suggesting that VOC levels in
the building were below those that might initiate TILT.
_ _
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APPENDIX: THE QEES'l
The Quick Environmental Exposure and Sensitivity Inventory (QEESI©) was developed
as a screening questionnaire for multiple chemical intolerances (MCI). (See Miller and
Prihoda 1999a, 1999b.) The instrument has four scales: symptom severity, chemical intol-
erances, other intolerances, and life impact. Each scale contains 10 items, scored from 0
= "not a problem" to 10 = "severe or disabling problem." A 10-item masking index
gauges ongoing exposures that may affect individuals' awareness of their intolerances as
well as the intensity of their responses to environmental exposures. Potential uses for the
QEESI include:
1. Research-to characterize and compare study populations, and to select subjects and
controls.
2. Clinical evaluations-to obtain a profile of patients' self-reported symptoms and intol-
erances. The QEESI can be administered at intervals to follow symptoms over time or
to document responses to treatment or exposure avoidance.
3. Workplace or community investigations-to identify and assist those who may be more
chemically susceptible or who report new intolerances. Affected individuals should
have the option of discussing results with investigators or their personal physicians.
Individuals whose symptoms began or intensified following a particular exposure event
can fill out the QEESI using two different ink colors, one showing how they were before
the event, and the second how they have been since the event. On the cover of the QEESI
is a "symptom star" (Figure 27.3), which provides a graphical representation of patients'
responses on the symptom severity scale.
Interpreting the QEESI©
In a study of 421 individuals, including four exposure groups and a control group, the
QEESI provided sensitivity of 92 percent and specificity of 95 percent in differentiating
between persons with multiple chemical intolerances and the general population (Miller
and Prihoda 1999a, 1999b).
Cronbach's alpha reliability coefficients for the QEESI's four scales-symptom sever-
ity, chemical intolerances, other intolerances, and life impact- were high (0.76 to 0.97) for
each of the groups, as well as over all subjects, indicating that the questions on the QEESI
form scales showing good internal consistency. Pearson correlations for each of the four
scales with validity items of interest, i.e., life quality, health status, energy level, body pain,
ability to work, and employment status, were all significant and in the expected direction,
thus supporting good construct validity.
Information on the development of this instrument, its interpretation, and results for
several populations have been published (Miller and Prihoda 1999a, 1999b). Proposed
ranges for the QEESI's scales and guidelines for their interpretation appear in Tables 27.6
and 27.7.
'For additional copies of the QEESI©, contact Claudia S. Miller, M.D., M.S., University of Texas Health Science
Center at San Antonio, Department of Family and Community Medicine, 7703 Floyd Curl Drive, San Antonio, TX
78229-3900. Phone: (210) 567-7760; fax: (210) 567-7764; email: millercs@uthscsa.edu. For further information see
Chemical Exposures: Low Levels and High Stakes by Nicholas A. Ashford and Claudia S. Miller, John Wiley & Sons,
1998 (1-800-225-5945).
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HEAD
COF
G
SKIN
FIGURE 27.3 QEESI symptom star illustrating symptom severity in an individual before and after an
exposure event (e.g., pesticide application, indoor air contaminants, chemical spill).
TABLE 27.6 Criteria for Low, Medium, and High Scale Scores
Score
Scale/index Low Medium High
Symptom severity 0-19 20-39 40-100
Chemical intolerance 0-19 20-39 40-100
Other intolerance 0-11 12-24 25-100
Life impact 0-11 12-23 24-100
Masking index 0-3 4-5 6-10
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